IRIS
CACCIOLA, Irene
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.154
NA - Nord America 3.302
AS - Asia 1.925
SA - Sud America 632
AF - Africa 81
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 10.101
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.245
RU - Federazione Russa 2.257
SG - Singapore 803
CN - Cina 564
BR - Brasile 540
IE - Irlanda 493
SE - Svezia 421
IT - Italia 356
HK - Hong Kong 207
DE - Germania 156
VN - Vietnam 107
FR - Francia 103
FI - Finlandia 74
GB - Regno Unito 73
UA - Ucraina 69
IN - India 65
PL - Polonia 51
AR - Argentina 37
BE - Belgio 27
ZA - Sudafrica 25
CA - Canada 24
BD - Bangladesh 21
JP - Giappone 21
TR - Turchia 21
MX - Messico 20
NL - Olanda 17
ID - Indonesia 16
AT - Austria 14
MA - Marocco 14
CO - Colombia 13
EC - Ecuador 13
UZ - Uzbekistan 13
IQ - Iraq 11
CL - Cile 10
PH - Filippine 9
PK - Pakistan 9
AZ - Azerbaigian 8
DZ - Algeria 8
ES - Italia 8
CZ - Repubblica Ceca 7
KE - Kenya 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
PY - Paraguay 6
EG - Egitto 5
JO - Giordania 5
LT - Lituania 5
CI - Costa d'Avorio 4
GR - Grecia 4
IL - Israele 4
KZ - Kazakistan 4
LB - Libano 4
MY - Malesia 4
PA - Panama 4
BO - Bolivia 3
IR - Iran 3
MD - Moldavia 3
NO - Norvegia 3
PE - Perù 3
PT - Portogallo 3
SA - Arabia Saudita 3
SN - Senegal 3
UY - Uruguay 3
VE - Venezuela 3
AL - Albania 2
AO - Angola 2
AU - Australia 2
EU - Europa 2
GE - Georgia 2
HR - Croazia 2
JM - Giamaica 2
KG - Kirghizistan 2
KR - Corea 2
NP - Nepal 2
NZ - Nuova Zelanda 2
OM - Oman 2
PS - Palestinian Territory 2
TG - Togo 2
TH - Thailandia 2
BA - Bosnia-Erzegovina 1
BW - Botswana 1
CH - Svizzera 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
KW - Kuwait 1
LC - Santa Lucia 1
LY - Libia 1
NG - Nigeria 1
QA - Qatar 1
RS - Serbia 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
TZ - Tanzania 1
Totale 10.100
Salva come PNG Salva come JPEG
Città #
Ashburn 670
Moscow 642
Singapore 496
Dublin 493
Dallas 489
Chandler 294
Nyköping 279
Hong Kong 207
Beijing 175
Messina 166
Jacksonville 147
San Jose 141
The Dalles 95
Los Angeles 94
Ann Arbor 75
Princeton 67
Medford 62
Lauterbourg 59
Munich 56
Des Moines 50
New York 47
São Paulo 45
Dearborn 44
Cambridge 40
Warsaw 40
Ho Chi Minh City 37
Boardman 29
Orem 28
Buffalo 25
Tianjin 25
Brussels 24
Hanoi 24
Jinan 24
Frankfurt am Main 21
Redondo Beach 21
Tokyo 21
Rio de Janeiro 19
Rosolini 19
Turku 19
Woodbridge 19
Belo Horizonte 17
Helsinki 17
Nuremberg 17
Seattle 17
Council Bluffs 16
Guangzhou 16
Houston 16
Hyderabad 16
Rome 16
Nanjing 15
Amsterdam 13
Catania 13
Santa Clara 13
Shanghai 13
Brooklyn 12
Chennai 12
San Francisco 12
San Mateo 12
Wilmington 12
Atlanta 11
Hebei 11
Jakarta 11
Johannesburg 11
Denver 10
Phoenix 10
Porto Alegre 10
Pune 10
Shenyang 10
Avola 9
Chicago 9
Shenzhen 9
Vienna 9
Ankara 8
Boston 8
Haikou 8
Hangzhou 8
Mumbai 8
Tashkent 8
Baku 7
Brasília 7
Bremen 7
Guayaquil 7
Haiphong 7
London 7
Pachino 7
Salvador 7
Stockholm 7
Baghdad 6
Cape Town 6
Dhaka 6
Düsseldorf 6
Manchester 6
Mexico City 6
Montreal 6
Querétaro 6
Recife 6
Casablanca 5
Changsha 5
Curitiba 5
Fuzhou 5
Totale 5.918
Salva come PNG Salva come JPEG
Nome #
Antibody to hepatitis B virus core antigen positivity is a predictor of non-alcoholic fatty liver disease severity 266
Acute kidney injury in cirrhotic patients undergoing contrast-enhanced computed tomography 264
Atrial fibrillation in patients with cirrhosis 244
Lack of the NS5B S282T mutation in HCV isolates from liver tissue of naive patients with HCV genotype-1b infection. 223
NS3 Variability in Hepatitis C Virus Genotype 1A Isolates from Liver Tissue and Serum Samples of Treatment-Naïve Patients with Chronic Hepatitis C 207
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study 202
Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases 200
Erectile dysfunction in compensated liver cirrhosis 197
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients 190
Cirrhotic Patients with Bacterial Infection and Negative Cultures Have a More Advanced Disease and an Increased Short-Term Mortality Rate 188
Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection 187
Elective endoscopic variceal ligation is not a risk factor for bacterial infection in patients with liver cirrhosis 187
Behaviour of occult HBV infection in HCV-infected patients under treatment with direct-acting antivirals 184
Fibroscan: a new non-invasive method for evaluation of liver dysfunction in Turner syndrome 180
Outcome of cutaneous psoriasis in hepatitis C virus-infected patients treated with Direct-Acting Antiviral therapy 180
Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients. 171
Prevalence of hepatitis B and C viral infections in hospitalized patients with increased liver enzyme levels and with no known history of hepatic disease 168
Evaluation of liver enzyme levels and identification of asymptomatic liver disease patients in primary care 166
Over time evaluation of glycaemic control in direct-acting antiviral-treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis 166
Rate of hepatocellular carcinoma diagnosis in cirrhotic patients with ultrasound‑detected liver nodules 164
Hepatitis E virus infection as a cause of acute hepatitis in Southern Italy 161
Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosis. 160
A Keynesian perspective on the health economics of kidney transplantation would strengthen the value of the whole organ donation and transplantation service 160
Hypergammaglobulinemia before Starting DAA Therapy Is A Strong Predictor of Disease Progression in Cirrhotic Patients Even after HCV Clearance 159
New-Onset Atrial Fibrillation and Early Mortality Rate in COVID-19 Patients: Association with IL-6 Serum Levels and Respiratory Distress 156
Oscillazione dei livelli di viremia in soggetti portatori cromici asintomatici di infezione da virus B. Dati preliminari 155
The HCV Sicily Network: A web-based model for the management of HCV chronic liver diseases 155
INTRAHEPATIC HDV RNA, HBV DNA, AND HBV RNAS QUANTIFICATIONS REVEAL SUPPRESSION OF HBV PREGENOME RNA PRODUCTION WITH MAINTENANCE OF PRES/S TRNSCRITION IN HDV/HBV CO-INFECTED PATIENTS 154
TT virus has a ubiquitous diffusion in human body tissues: analyses of paired serum and tissue samples. 153
Effectiveness of add-on Pegylated interferon alfa-2a therapy in a Lamivudine-treated patient with chronic hepatitis B 150
Genomic heterogeneity of hepatitis B virus (HBV) and outcome of perinatal HBV infection. 147
Replicative and transcriptional activities of hepatitis B virus in patients coinfected with hepatitis B and hepatitis delta viruses. 143
Assessing Genomic Mutations in SARS-CoV-2: Potential Resistance to Antiviral Drugs in Viral Populations from Untreated COVID-19 Patients 142
Molecular analyses of TT virus in paired and tissue samples from 150 patients with either hepatic or non-hepatic disease 139
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents. 138
Health economics aspects of kidney transplantation in Sicily: a benchmark analysis on activity and estimated savings 137
Oscillazione dei livelli di viremia in soggetti portatori cronici asintomatici di infezione da virus b. Dati preliminari 137
Fever and rhomboid target lesion in decompensated cirrhosis 137
Virological profiles in hepatitis B virus inactive carriers: monthly evaluation in 1-year follow-up study 133
Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C 127
Impact of Occult Hepatitis B Virus Infection on the Outcome of Chronic Hepatitis C. 127
Dermatiti iatrogene in corso di trattamento dell’epatopatia HCV-correlata con simeprevir 127
Strain endocardico longitudinale tra pazienti cirrotici di classe A e B al punteggio di Child-Pugh 126
Long-term response to interferon alpha is unrelated to "interferon sensitivity determining region" variability in patients with chronic hepatitis C virus-1b infection 125
Hepatitis B virus PreS/S gene variants: Pathobiology and clinical implications. 125
Mucocutaneous toxicity during simeprevir treatment for hepatitis C. A single institution, retrospective case series 121
Pre-S2 defective hepatitis B virus infection in patients with fulminant hepatitis. 119
Impact of Sex and Gender on Clinical Management of Patients with Advanced Chronic Liver Disease and Type 2 Diabetes 118
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial. 118
High Prevalence of Severe Hepatic Fibrosis in Type 2 Diabetic Outpatients Screened for Non-Alcoholic Fatty Liver Disease 112
Long-term virological and clinical evaluation of chronic hepatitis B patients under nucleos(t)ide analogues therapy 111
Quantification of intrahepatic hepatitis B virus (HBV) DNA in patients with chronic HBV infection. 109
NS3 Q80K Polymorphism in viral isolates from Liver Tissues and serum samples of naive HCV genotype 1a Patients 109
ACUTE KIDNEY INJURY IN CIRRHOTIC PATIENTS UNDERGOING CONTRAST-ENHANCED COMPUTED TOMOGRAPHY 107
Virological profiles in patients with chronic hepatitis C and overt or occult HBV infection. 105
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 105
Is Transient Elastography Needed for Noninvasive Assessment of High-Risk Varices? The REAL Experience 102
Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease 101
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry 100
Effects of Proton Pump Inhibitors in Cirrhotic Patients: What Do We Really Know? 99
PREVALENCE OF BACTERIAL RESISTANCE IN CIRRHOTIC PATIENTS WITH BACTERIAL INFECTION: A PRELIMINARY REPORT 97
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 96
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 94
Infezione occulta da virus dell’epatite B in pazienti con epatite cronica virus con correlata valutazione istologica 93
Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination 91
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis. 91
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis 89
The impact of infection by multidrug-resistant agents in patients with cirrhosis. A multicenter prospective study 87
Occult hepatitis B virus infection 73
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 71
Liver and cardiovascular mortality after hepatitis C virus eradication by DAA: Data from RESIST-HCV cohort 71
Impact of Proton Pump Inhibitor Use on Progression-Free and Overall Survival in Cancer Patients Undergoing Immune Checkpoint Inhibitor Therapy: A Systematic Review and Meta-Analysis of Recent Studies 57
RESIST-HCV criteria to monitor progression of low-risk esophageal varices in patients with compensated cirrhosis after HCV eradication. The SIMPLE study 39
Incidence and Recurrence of Portal Vein Thrombosis in Cirrhotic Patients 38
MASLD Under the Microscope: How microRNAs and Microbiota Shape Hepatic Metabolic Disease Progression 29
null 22
null 20
Tumour Burden Score as a Predictor of Extrahepatic Progression After Transarterial Chemoembolizationfor Hepatocellular Carcinoma: An Observational Multicenter Study 6
Risk Factors of Metabolic Dysfunction-associated Steatotic Liver Disease in a Cohort of Patients With Chronic Hepatitis B 5
The Innovative Potential of Artificial Intelligence Applied to Patient Registries to Implement Clinical Guidelines 4
From Cure to Complexity: Post-SVR Liver and Metabolic Trajectories in Diabetic Patients 4
Trabecular bone score enhances fracture risk stratification in patients with metabolic dysfunction-associated steatotic liver disease and type 2 diabetes mellitus 3
Neurofilament light chain proteins are a sensitive biomarker of neuronal damage in cirrhotic patients with hepatic encephalopathy 3
Investigating the Impact of Fusobacterium nucleatum on Oxidative Stress, Chemoresistance, and Inflammation in Inflammatory Bowel Disease and Colorectal Cancer: Rationale and Design of a Clinical Trial 2
Sex-based differences in hepatitis delta virus infection: Insights from the Italian PITER hepatitis delta virus cohort 2
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort 1
Effects of Proton Pump Inhibitors in Cirrhotic Patients: What Do We Really Know? 1
Totale 10.332
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.944
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.944
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202183 0 0 0 0 0 0 0 0 0 45 22 16
2021/2022481 13 53 14 14 36 4 52 11 7 66 65 146
2022/20231.347 81 162 73 89 86 127 32 77 556 7 37 20
2023/2024340 27 61 20 36 31 44 7 10 3 44 18 39
2024/20251.668 30 27 44 118 77 71 83 326 378 89 167 258
2025/20265.445 278 467 420 357 433 1.104 700 699 732 255 0 0
Totale 10.332